Literature DB >> 31965984

The role of histone modifications in leukemogenesis.

Noah W Birch1, Ali Shilatifard.   

Abstract

Histone modifications play a critical role in coordinating accurate gene expression. Aside from genetic mutations which cause altered DNA sequence, it has become increasingly clear that aberrant post-translational modifications of histone tails are also associated with leukemogenesis. The functional roles of specific histone marks has informed the basis of our understanding for underlying mechanisms of leukemia, while global analyses of interacting histone modifications has begun to distinguish subtypes of leukemia with prognostic and therapeutic implications. In this current era of personalized and precision medicine, it will be necessary to not only identify the specific genetic mutations present in a patient's leukemia but to also appreciate the dynamic chromatin states which are driven by histone modifications that can aid our diagnostic and therapeutic strategies for improved management of leukemia.

Entities:  

Year:  2020        PMID: 31965984

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  28 in total

1.  Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes.

Authors:  Andrew J Bannister; Robert Schneider; Fiona A Myers; Alan W Thorne; Colyn Crane-Robinson; Tony Kouzarides
Journal:  J Biol Chem       Date:  2005-03-10       Impact factor: 5.157

2.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

Review 3.  Transcriptional enhancers: from properties to genome-wide predictions.

Authors:  Daria Shlyueva; Gerald Stampfel; Alexander Stark
Journal:  Nat Rev Genet       Date:  2014-03-11       Impact factor: 53.242

4.  Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.

Authors:  Donna A Santillan; Catherine M Theisler; Amanda S Ryan; Relja Popovic; Tara Stuart; Ming-Ming Zhou; Serhan Alkan; Nancy J Zeleznik-Le
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

Review 5.  Enhancer Logic and Mechanics in Development and Disease.

Authors:  Ryan Rickels; Ali Shilatifard
Journal:  Trends Cell Biol       Date:  2018-05-11       Impact factor: 20.808

6.  MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

Authors:  Kathrin M Bernt; Nan Zhu; Amit U Sinha; Sridhar Vempati; Joerg Faber; Andrei V Krivtsov; Zhaohui Feng; Natalie Punt; Amanda Daigle; Lars Bullinger; Roy M Pollock; Victoria M Richon; Andrew L Kung; Scott A Armstrong
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

Review 7.  Histone Modifications and Cancer.

Authors:  James E Audia; Robert M Campbell
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-04-01       Impact factor: 10.005

8.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

9.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

10.  Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.

Authors:  Panagiotis Ntziachristos; Aristotelis Tsirigos; G Grant Welstead; Thomas Trimarchi; Sofia Bakogianni; Luyao Xu; Evangelia Loizou; Linda Holmfeldt; Alexandros Strikoudis; Bryan King; Jasper Mullenders; Jared Becksfort; Jelena Nedjic; Elisabeth Paietta; Martin S Tallman; Jacob M Rowe; Giovanni Tonon; Takashi Satoh; Laurens Kruidenier; Rab Prinjha; Shizuo Akira; Pieter Van Vlierberghe; Adolfo A Ferrando; Rudolf Jaenisch; Charles G Mullighan; Iannis Aifantis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.